Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Pre-Market Session

Author: Benzinga Insights | November 20, 2023 09:06am

Gainers

  • Altamira Therapeutics (NASDAQ:CYTO) stock rose 27.7% to $0.36 during Monday's pre-market session. The company's market cap stands at $2.8 million.
  • LogicMark (NASDAQ:LGMK) stock increased by 22.15% to $2.04. The company's market cap stands at $2.8 million.
  • TRACON Pharma (NASDAQ:TCON) stock moved upwards by 20.9% to $0.2. The company's market cap stands at $6.3 million.
  • MediciNova (NASDAQ:MNOV) stock rose 16.29% to $2.07. The market value of their outstanding shares is at $101.5 million.
  • Kronos Bio (NASDAQ:KRON) stock moved upwards by 15.31% to $1.28. The company's market cap stands at $74.6 million.
  • Heart Test Laboratories (NASDAQ:HSCS) shares increased by 14.66% to $0.19. The market value of their outstanding shares is at $4.1 million.

Losers

  • Intelligent Bio Solutions (NASDAQ:INBS) shares decreased by 30.0% to $0.32 during Monday's pre-market session. The market value of their outstanding shares is at $2.7 million.
  • Yield10 Bioscience (NASDAQ:YTEN) shares decreased by 22.23% to $0.21. The company's market cap stands at $2.4 million. As per the news, the Q3 earnings report came out 4 days ago.
  • Vera Therapeutics (NASDAQ:VERA) stock fell 12.78% to $11.94. The market value of their outstanding shares is at $530.5 million.
  • Aligos Therapeutics (NASDAQ:ALGS) shares fell 12.54% to $0.6. The company's market cap stands at $44.9 million.
  • Bone Biologics (NASDAQ:BBLG) stock decreased by 10.66% to $0.55. The company's market cap stands at $1.7 million. The company's, Q3 earnings came out 4 days ago.
  • Dermata Therapeutics (NASDAQ:DRMA) stock fell 10.46% to $0.63. The market value of their outstanding shares is at $1.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALGS BBLG CYTO DRMA HSCS INBS KRON LGMK MNOV TCON VERA YTEN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist